Key points
Two types of COVID-19 vaccines are recommended for use in the United States: mRNA vaccines (Moderna and Pfizer-BioNTech) and a protein subunit vaccine (Novavax).
Recommendations
Vaccination is based on individual-based decision-making (also known as shared clinical decision-making). Schedules and dosing for the 2026–2027 COVID-19 vaccines are based on age and immune status.
Clinical tools
Immunization schedules
Prevaccination screening checklist
- Screening Checklist for Contraindications to Vaccination for Adults
- Screening Checklist for Contraindications to Vaccination for Children and Teens
Education for patients and parents
Immunization providers should provide a Vaccine Information Statement (VIS) to a patient, parent, or legal representative before each dose of COVID-19 vaccine.
Storage labels
Includes labels and beyond-use date guidance for flu, COVID-19, and RSV immunization products
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.